# FDA Inspection 1240363 - Empire Medical Office, P.C. - May 28, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/empire-medical-office-pc/1c463419-6629-4f88-9b76-46bb70265d2c/
Source feed: FDA_Inspections

> FDA Inspection 1240363 for Empire Medical Office, P.C. on May 28, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1240363
- Company Name: Empire Medical Office, P.C.
- Inspection Date: 2024-05-28
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1151607 - 2021-09-03](https://www.globalkeysolutions.net/api/records/fda_inspections/empire-medical-office-pc/42105420-622d-4ed8-a4c7-33e41318f671/)
- [FDA Inspection 1151607 - 2021-09-03](https://www.globalkeysolutions.net/api/records/fda_inspections/empire-medical-office-pc/e670ab8f-548d-4cb0-b07d-8314a59665e0/)
- [FDA Inspection 1151607 - 2021-09-03](https://www.globalkeysolutions.net/api/records/fda_inspections/empire-medical-office-pc/cb7d38bd-f498-497d-8757-2095bfd03e1a/)

Company: https://www.globalkeysolutions.net/companies/empire-medical-office-pc/0117968f-e180-42ad-a2e7-9e83fc85419a

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d